Repigmentation of vitiligo with pimecrolimus cream: A case report

Dermatology

Volumn 207, Issue 3, 2003, Pages 322-323

  Mayoral, Flor A ^a   Gonzalez, Caridad ^b   Shah, Neha S ^b   Arciniegas, Cynthia ^b  

^a Penthouse W   (United States)

^b NONE

Author keywords

Pimecrolimus; Repigmentation; Vitiligo

Indexed keywords

CLOBETASOL PROPIONATE; METHOXSALEN; PIMECROLIMUS; PLACENTA EXTRACT; POLYPODIUM LEUCOTOMOS EXTRACT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; SKIN PIGMENTATION; TREATMENT OUTCOME; VITILIGO;

ADMINISTRATION, CUTANEOUS; ADULT; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; OINTMENTS; PIGMENTATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME; VITILIGO;

EID: 0142258867     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073099     Document Type: Article

References (4)

1. Kovacs SO: Vitiligo. J Am Acad Dermatol 1998;38:647-666.
2. Grimes PE, Soriano T, Dytoc MT: Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002;47:789-791.
3. Smith DA, Tofte SJ, Hanifin JM: Repigmentation of vitiligo with topical tacrolimus. Dermatology 2002;205:301-303.
4. Grassberger M, Baumruker T, Enz A, Hiestand P, Hultsch T, Kalthoff F, Schuler W, Schulz M, Werner FJ, Winiski A, Wolff B, Zenke G: A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology. Br J Dermatol 1999;141:264-273.